These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 32960493)
1. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS. Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493 [TBL] [Abstract][Full Text] [Related]
2. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies. Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826 [TBL] [Abstract][Full Text] [Related]
4. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery. Choi ES; Shusta EV Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619 [TBL] [Abstract][Full Text] [Related]
5. Cryopreservation of Brain Endothelial Cells Derived from Human Induced Pluripotent Stem Cells Is Enhanced by Rho-Associated Coiled Coil-Containing Kinase Inhibition. Wilson HK; Faubion MG; Hjortness MK; Palecek SP; Shusta EV Tissue Eng Part C Methods; 2016 Dec; 22(12):1085-1094. PubMed ID: 27846787 [TBL] [Abstract][Full Text] [Related]
6. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system. Thom G; Hatcher J; Hearn A; Paterson J; Rodrigo N; Beljean A; Gurrell I; Webster C MAbs; 2018; 10(2):304-314. PubMed ID: 29182455 [TBL] [Abstract][Full Text] [Related]
7. Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells. Stebbins MJ; Lippmann ES; Faubion MG; Daneman R; Palecek SP; Shusta EV Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 28960887 [TBL] [Abstract][Full Text] [Related]
8. A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis. Ribecco-Lutkiewicz M; Sodja C; Haukenfrers J; Haqqani AS; Ly D; Zachar P; Baumann E; Ball M; Huang J; Rukhlova M; Martina M; Liu Q; Stanimirovic D; Jezierski A; Bani-Yaghoub M Sci Rep; 2018 Jan; 8(1):1873. PubMed ID: 29382846 [TBL] [Abstract][Full Text] [Related]
14. Receptor-mediated transcytosis of macromolecules across the blood-brain barrier. Baghirov H Expert Opin Drug Deliv; 2023; 20(12):1699-1711. PubMed ID: 37658673 [TBL] [Abstract][Full Text] [Related]
15. Antibody-Targeted Liposomes for Enhanced Targeting of the Blood-Brain Barrier. Ye Z; Gastfriend BD; Umlauf BJ; Lynn DM; Shusta EV Pharm Res; 2022 Jul; 39(7):1523-1534. PubMed ID: 35169958 [TBL] [Abstract][Full Text] [Related]